help button home button Biophys. J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Biophysical Journal 67: 2167-2183 (1994)
© 1994 the Biophysical Society

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Herron, J N
Right arrow Articles by Edmundson, A B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Herron, J N
Right arrow Articles by Edmundson, A B

High resolution structures of the 4-4-20 Fab-fluorescein complex in two solvent systems: effects of solvent on structure and antigen-binding affinity.

J N Herron, A H Terry, S Johnston, X M He, L W Guddat, E W Voss, Jr and A B Edmundson

Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City 84112.

ABSTRACT

Three-dimensional structures were determined for three crystal forms of the antigen binding fragment (Fab) of anti-fluorescein antibody 4-4-20 in complex with fluorescein. These included 1) a triclinic (P1) form crystallized in 47% (v/v) 2-methyl-2,4-pentanediol (MPD); 2) a triclinic (P1) form crystallized in 16% (w/v) poly(ethylene glycol), molecular weight 3350 (PEG); and 3) a monoclinic (P21) form crystallized in 16% PEG. Solvent molecules were added to the three models and the structures were refined to their diffraction limits (1.75-A, 1.78-A, and 2.49-A resolution for the MPD, triclinic PEG, and monoclinic PEG forms, respectively). Comparisons of these structures were interesting because 4-4-20 exhibited a lower antigen-binding affinity in 47% MPD (Ka = 1.3 x 10(8) M-1) than in either 16% PEG (Ka = 2.9 x 10(9) M-1) or phosphate-buffered saline (Ka = 1.8 x 10(10) M-1). Even though the solution behavior of the antibody was significantly different in MPD and PEG, the crystal structures were remarkably similar. In all three structures, the fluorescein-combining site was an aromatic slot formed by tyrosines L32, H96, and H97 and tryptophans L96 and H33. In addition, several active site constituents formed an electrostatic network with the ligand. These included a salt link between arginine L34 and one of fluorescein's enolate oxygen atoms, a hydrogen bond between histidine L27d and the second enolic group, a hydrogen bond between tyrosine L32 and the phenylcarboxylate group, and two medium range (approximately 5 A) electrostatic interactions with lysine L50 and arginine H52. The only major difference between the triclinic MPD and PEG structures was the degree of hydration of the antigen-combining site. Three water molecules participated in the above electrostatic network in the MPD structure, while eight were involved in the PEG structure. Based on this observation, we believe that 4-4-20 exhibits a lower affinity in MPD due to the depletion of the hydration shell of the antigen-combining site.




This article has been cited by other articles:


Home page
Protein Sci.Home page
K. S. Midelfort and K. D. Wittrup
Context-dependent mutations predominate in an engineered high-affinity single chain antibody fragment
Protein Sci., February 1, 2006; 15(2): 324 - 334.
[Abstract] [Full Text] [PDF]


Home page
Protein Sci.Home page
A. Honegger, S. Spinelli, C. Cambillau, and A. Pluckthun
A mutation designed to alter crystal packing permits structural analysis of a tight-binding fluorescein-scFv complex
Protein Sci., October 1, 2005; 14(10): 2537 - 2549.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Jimenez, G. Salazar, K. K. Baldridge, and F. E. Romesberg
From the Cover: Flexibility and molecular recognition in the immune system
PNAS, January 7, 2003; 100(1): 92 - 97.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. T. Boder, K. S. Midelfort, and K. D. Wittrup
Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity
PNAS, September 8, 2000; (2000) 170297297.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
K. Lim, S. M. Owens, L. Arnold, J. C. Sacchettini, and D. S. Linthicum
Crystal Structure of Monoclonal 6B5 Fab Complexed with Phencyclidine
J. Biol. Chem., October 30, 1998; 273(44): 28576 - 28582.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Carrero, W. D. Mallender, and E. W. Voss Jr.
Anti-metatype Antibody Stabilization of Fv 4-4-20 Variable Domain Dynamics
J. Biol. Chem., May 10, 1996; 271(19): 11247 - 11252.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Carrero and E. W. Voss Jr.
Temperature and pH Dependence of Fluorescein Binding within the Monoclonal Antibody 9-40 Active Site as Monitored by Hydrostatic Pressure
J. Biol. Chem., March 8, 1996; 271(10): 5332 - 5337.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. D. Mallender, J. Carrero, and E. W. Voss Jr.
Comparative Properties of the Single Chain Antibody and Fv Derivatives of mAb 4-4-20
J. Biol. Chem., March 8, 1996; 271(10): 5338 - 5346.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. T. Boder, K. S. Midelfort, and K. D. Wittrup
Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity
PNAS, September 26, 2000; 97(20): 10701 - 10705.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the Biophysical Society.